BARBANTI, PIERO
 Distribuzione geografica
Continente #
NA - Nord America 4.787
AS - Asia 3.565
EU - Europa 1.069
SA - Sud America 455
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 67
OC - Oceania 13
Totale 10.037
Nazione #
US - Stati Uniti d'America 4.292
TR - Turchia 1.061
SG - Singapore 918
CN - Cina 744
CA - Canada 456
IT - Italia 441
BR - Brasile 343
VN - Vietnam 284
BD - Bangladesh 119
IN - India 95
FR - Francia 91
HK - Hong Kong 90
DE - Germania 89
GB - Regno Unito 73
UA - Ucraina 72
IE - Irlanda 71
EU - Europa 65
PK - Pakistan 59
RU - Federazione Russa 58
AR - Argentina 42
ID - Indonesia 37
IL - Israele 37
FI - Finlandia 36
NL - Olanda 31
ES - Italia 24
MX - Messico 23
EC - Ecuador 17
ZA - Sudafrica 17
SC - Seychelles 16
CO - Colombia 15
JP - Giappone 15
IQ - Iraq 14
MY - Malesia 14
VE - Venezuela 14
PL - Polonia 13
SE - Svezia 13
PH - Filippine 12
KE - Kenya 11
AU - Australia 10
CL - Cile 8
EG - Egitto 8
KZ - Kazakistan 8
PY - Paraguay 7
SA - Arabia Saudita 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
DZ - Algeria 6
MA - Marocco 6
NP - Nepal 6
RO - Romania 6
TN - Tunisia 6
UZ - Uzbekistan 6
IR - Iran 5
KR - Corea 5
PT - Portogallo 5
RS - Serbia 5
TW - Taiwan 5
DK - Danimarca 4
JO - Giordania 4
MD - Moldavia 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
CR - Costa Rica 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AF - Afghanistan, Repubblica islamica di 2
BE - Belgio 2
BG - Bulgaria 2
BW - Botswana 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
LB - Libano 2
LT - Lituania 2
LY - Libia 2
MN - Mongolia 2
MT - Malta 2
NI - Nicaragua 2
OM - Oman 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
Totale 10.030
Città #
Kocaeli 926
San Mateo 664
Dallas 625
San Jose 599
Toronto 423
Ashburn 405
Singapore 276
Wilmington 223
Rome 220
Beijing 217
Santa Clara 207
Houston 182
Lawrence 140
Princeton 140
Ho Chi Minh City 115
Hong Kong 86
Los Angeles 76
Fairfield 74
Seattle 55
Hanoi 54
New York 52
Chandler 49
West Jordan 46
Islamabad 45
Redwood City 43
Shanghai 43
Frankfurt am Main 41
São Paulo 41
Woodbridge 34
Netanya 31
Brooklyn 29
Milan 27
Guangzhou 26
Helsinki 26
Cambridge 25
Dublin 24
Council Bluffs 16
Chicago 15
Jakarta 15
Orem 15
Mexico City 13
Shenzhen 13
Vicenza 13
Amsterdam 12
Montreal 12
Haiphong 11
Kuala Selangor 11
London 11
Munich 11
Rio de Janeiro 11
Tokyo 11
Nairobi 10
Suffern 10
Atlanta 9
Buffalo 9
Boston 8
Charlotte 8
Denver 8
Saint Petersburg 8
San Francisco 8
Andover 7
Biên Hòa 7
Chennai 7
Curitiba 7
Da Nang 7
Dhaka 7
Florence 7
Johannesburg 7
Mumbai 7
Naples 7
Philadelphia 7
Phoenix 7
Quito 7
Roubaix 7
Rui'an 7
Secaucus 7
The Dalles 7
Turku 7
Wuhan 7
Almaty 6
Ankara 6
Bexley 6
Ha Long 6
Pune 6
St Petersburg 6
Warsaw 6
Washington 6
Wroclaw 6
Wuxi 6
Ann Arbor 5
Belo Horizonte 5
Borås 5
Buenos Aires 5
Guayaquil 5
Hải Dương 5
Jiaxing 5
Kansas City 5
Karachi 5
Manchester 5
Miami 5
Totale 6.805
Nome #
A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) 346
Rationale for use of onabotulinum toxin A (BOTOX) in chronic migraine 136
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 133
Amitriptyline in preventive treatment of tension headaches in non-depressed patients is efficient for chronic, but not for episodic cases 129
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study 127
Donepezil in the treatment of hallucinations and delusions in Parkinson's disease 117
A case-control study on excessive daytime sleepiness in chronic migraine 104
A case-control study on excessive daytime sleepiness in chronic migraine 101
A meta-analysis of biomarkers related to oxidative stress and nitric oxide pathway in migraine 98
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 98
A case - control study on excessive daytime sleepiness in episodic migraine 98
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 89
Clinical features, disease progresson and use of healthcare resoiurces in a large sample of 866 patients from 24 headaches centers: a real-life perspective from the italian chronic migraiNE (IRON) project 87
Ketogenic diet in migraine: rationale, findings and perspectives 83
Hypertension as a risk factor for migraine chronification 80
Amitriptyline is effective in chronic but not in episodic tension-type headache: Pathogenetic implications 79
An open study with reversible MAO-A inhibitors in complicated Parkinson's disease 78
Non-invasive Vagus Nerve Stimulation (nVNS) as mini-prophylaxis for menstrual/menstrually related migraine: an open-label study 77
Acupuncture in cluster headache: Four cases and review of the literature 77
Restless legs syndrome is not associated with migraine with aura: a clinical study 76
Polymorphism at codon 129 or codon 219 of PRNP and clinical heterogeneity in a previously unreported family with Gerstmann-Straussler-Scheinker disease (PrP-P102L mutation) 75
Prolonged muscular flaccidity after stroke morphological and functional brain alterations 75
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 75
A mechanism-based classification of pain in multiple sclerosis 74
Early (<= 1-h) vs. late (> 1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 74
Prolonged muscular flaccidity: frequency and association with unilateral spatial neglect after stroke 74
Erenumab in the prevention of high-frequency episodic and chronic migraine: Erenumab in Real Life in Italy (EARLY), the first Italian multicenter, prospective real-life study 74
Unilateral cranial autonomic symptoms in migraine 73
Acute pathological laughter induced by sumatriptan 71
Dopamine hypersensitivity in migraine: Role of the apomorphine test 71
Association of 24-h productivity with 2-h pain-free rates following administration of a fast disintegrating/rapid release formulation of sumatriptan 70
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study 70
Migraine as a Cortical Brain Disorder 70
Treatment of tension-type headache: from old myths to modern concepts 69
Prolonged muscular flaccidity in stroke patients is associated with crossed cerebellar diaschisis 69
Tardive dyskinesias in the elderly 67
Machine learning approach to predict medication overuse in migraine patients 67
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial 66
Late motor recovery is influenced by muscle tone changes after stroke 66
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease 66
Increased expression of dopamine receptors on lymphocytes in Parkinson's disease 66
Real-world insights on the management of migraine patients: an Italian nationwide study 66
Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes 65
Dopamine and migraine: Does Parkinson's disease modify migraine course? 65
Dopaminergic symptoms in migraine: A cross-sectional study on 1148 consecutive headache center-based patients 65
Pharmacotherapy for acute migraines in children and adolescents 65
The role of anti-CGRP antibodies in the pathophysiology of primary headaches 64
Dopamine and migraine: does Parkinson's disease modify the course of migraine? 64
Cluster headache: management of acute attacks before triptans 64
A proposal for a national registry on chronic migraines 64
Migraine and Tourette syndrome 64
Future trends in drugs for migraine prophylaxis 64
Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine 64
Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment 63
BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study 63
Differences in short-term primary motor cortex plasticity as assessed by repetitive transcranial magnetic stimulation in migraine with and without aura 62
Tension type headache: a neuropsychological and neurophysiological study 62
Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations 62
The evaluation of difficulties with work-related activities caused by migraine: towards a specific questionnaire 62
Impact of the International Headache Society criteria on the use of neuroimaging for headache diagnosis in a headache clinic 62
Establishment of a biorepository for migraine research: the experience of Interinstitutional Multidisciplinary BioBank (BioBIM) 61
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura 61
Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine 61
Donepezil in the treatment of progressive supranuclear palsy 61
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 61
Migraine and movement disorders 61
NON-INVASIVE VAGUS NERVE STIMULATION (NVNS) FOR THE ACUTE TREATMENT OF MIGRAINE WITHOUT AURA IN ADOLESCENTS: PRELIMINARY CLINICAL EXPERIENCE 61
Cerebral Transverse Sinus Morphology As Detected by MR Venography in Patients With Chronic Migraine 61
Open-label Pilot Study of Non-invasive Vagus Nerve Stimulation for the Prevention of Menstrual Migraine and Menstrually Related Migraine 61
Erenumab during pregnancy: a case report in a patient with chronic migraine 61
Association of LTA and SOD Gene Polymorphisms with Cerebral White Matter Hyperintensities in Migraine Patients 60
Association between Migraine and Progesterone Receptor Gene PROGINS Polymorphism: the BioBIM study 60
Comparison of frovatriptan plus dexketoprofen (25mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study 60
Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study 60
Non-invasive vagus nerve stimulation (nVNS) as symptomatic treatment of migraine in young patients: a preliminary safety study 59
Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test 58
Chronic migraine: treatability, refractoriness, pseudo-refractoriness 58
Creutzfeldt-Jakob disease and related disorders: Etiopathogenetic aspects 57
Prevalence and Time Course of Post-Stroke Pain: A Multicenter Prospective Hospital-Based Study 57
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 57
Migraine prophylaxis: what is new and what we need? 57
Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial 57
Look beyond COMT genotype for cathecolamines derangement in migraine: the biobim rs4818 and rs4680 polymorphisms study 56
Migraine attack delays gastric emptying: an ultrasonographic study 56
Impairment of trigeminal sensory pathways in cluster headache 56
Shortened cortical silent period in facial muscles of patients with migraine 56
Validation of a self-reported instrument to assess work-related difficulties in patients with migraine: the HEADWORK questionnaire 56
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients 55
HEADACHE FREQUENCY AND CHARACTERISTICS IN CHRONIC COCAINE USERS: A CROSS SECTIONAL STUDY 55
Efficacy and Safety of Frovatriptan plus Dexketoprofen in Menstrual Related Migraine (MRM) 55
Trigeminal sensory pathway function in patients with SUNCT 54
Drugs targeting nitric oxide synthase for migraine treatment 54
Socio-economic costs of migraine 54
Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 54
Headache in chronic cocaine users: A cross-sectional study 53
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial 53
Increased density of dopamine D-5 receptor in peripheral blood lymphocytes of migraineurs: A masker for migraine? 52
Cocaine and headache: a 2-year follow-up study in chronic cocaine users and literature review 52
Migraine and the extrapyramidal system 51
Role of neurostimulation in migraine 51
Totale 7.188
Categoria #
all - tutte 87.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.735


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 0 0 62
2021/20221.377 18 419 425 6 2 0 103 162 16 200 11 15
2022/2023468 319 8 4 18 16 5 12 16 16 26 22 6
2023/2024387 5 2 9 46 14 52 1 27 0 85 3 143
2024/20251.519 81 221 128 52 86 257 111 107 176 22 39 239
2025/20264.409 259 356 662 381 269 461 521 265 504 446 226 59
Totale 10.269